Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients With N2/N3 Locally Advanced Head and Neck Cancer

NCT00117572 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00117572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00117572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients With N2/N3 Locally Advanced Head and Neck Cancer
Lead sponsor
University of Chicago
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
December 31, 2016
Enrollment
285 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the larynx, cancer of the nasal cavity, cancer of the oral cavity, cancer of the pharynx, paranasal sinus neoplasms